ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Phase 3

Selank

Selank

Also known as: TP-7, Selanc

Overview

Key Facts

Primary Goal: A synthetic heptapeptide anxiolytic derived from the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with the same Pro-Gly-Pro stabilizing extension used in Semax

A synthetic heptapeptide anxiolytic derived from the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with the same Pro-Gly-Pro stabilizing extension used in Semax. Developed alongside Semax at the Institute of Molecular Genetics in Russia, Selank is approved there as an anxiolytic and nootropic with immunomodulatory properties. Half-Life ~several minutes (active metabolites persist 3-5 hours) Typical Dose 150–500 mcg Frequency 1-3 times daily Cycle Length 14-30 days

Dosing Information

Half-Life

~several minutes (active metabolites persist 3-5 hours)

Typical Dose

150–500 mcg

Frequency

1-3 times daily

Cycle Length

14-30 days

Administration Routes:

subcutaneous

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Phase 3

Selank was approved in Russia in 2009 for generalized anxiety disorder and as a nootropic. Clinical studies demonstrated anxiolytic efficacy comparable to medazepam (a benzodiazepine) without sedation, cognitive impairment, or withdrawal symptoms. Research has confirmed its influence on over 50 genes related to GABAergic signaling, serotonin transport, and immune function. Its dual anxiolytic-immunomodulatory profile is unique among peptide-based compounds.

Frequently Asked Questions

Common questions about Selank

UK-Specific Information

Exclusive data points and guidance for UK residents using Selank

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With